Form 4: Amprius Technologies Executive Sells Shares to Cover Tax Obligations

Jonathan Bornstein, President of Amprius Lab, sold shares of Amprius Technologies to cover tax obligations related to vesting restricted stock units.

Summary

• On February 21, 2025, Jonathan Bornstein, President of Amprius Lab at Amprius Technologies, sold 13,527 shares of common stock at an average price of $3.1332 per share.
• The sale was executed to cover tax withholding obligations associated with the vesting of restricted stock units.
• Following the transaction, Bornstein directly owns 419,197 shares and indirectly owns 1,062,357 shares through the Jonathan G. Bornstein and Phyllis S. Brock Trust Agreement.
• On February 24, 2025, Bornstein transferred 21,407 shares to the Jonathan G. Bornstein and Phyllis S. Brock Trust Agreement.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the transaction appears to be a routine sale to cover tax obligations, with no indication of a change in the executive's confidence in the company.

Industry Context

Form 4 filings are standard disclosures required by the SEC when company insiders, like officers and directors, trade their company's stock. These filings provide transparency into insider transactions and can be scrutinized by investors for insights into management's perspective on the company's value and future prospects. However, sales to cover tax obligations are common and don't necessarily indicate a negative outlook.

Key Dates

Keywords

Amprius Technologies, Jonathan Bornstein, AMPX, stock sale, Form 4, insider trading, restricted stock units, tax obligations